المؤلفون: Delgado-Lista, Javier, Mostaza, Jose M., Arrobas-Velilla, Teresa, Blanco-Vaca, Francisco, Masana, Luis, Pedro-Botet, Juan, Perez-Martinez, Pablo, Civeira, Fernando, Cuende-Melero, Jose I., Gomez-Barrado, Jose J., Lahoz, Carlos, Pintó, Xavier, Suarez-Tembra, Manuel, Lopez-Miranda, Jose, Guijarro, Carlos

المصدر: Clínica e Investigación en Arteriosclerosis ; ISSN 0214-9168

مصطلحات موضوعية: Pharmacology (medical), Cardiology and Cardiovascular Medicine

الإتاحة: https://doi.org/10.1016/j.arteri.2024.03.002Test
https://api.elsevier.com/content/article/PII:S0214916824000238?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0214916824000238?httpAccept=text/plainTest

المؤلفون: SANTORINI Study Investigators, Ray, Kausik K., Haq, Inaam, Bilitou, Aikaterini, Manu, Marius C., Burden, Annie, Aguiar, Carlos, Arca, Marcello, Connolly, Derek L., Eriksson, Mats, Ferrieres, Jean, Laufs, Ulrich, Mostaza, Jose M., Nanchen, David, Rietzschel, Ernst, Strandberg, Timo, Toplak, Hermann, Visseren, Frank L. J., Catapano, Alberico L.

المساهمون: HUS Internal Medicine and Rehabilitation, Timo Strandberg / Principal Investigator, Department of Medicine, Clinicum

مصطلحات موضوعية: Cardiovascular disease, Cohort study, High cardiovascular risk, LDL cholesterol, Lipid-lowering therapy, Real-world evidence, 3141 Health care science

وصف الملف: application/pdf

العلاقة: SANTORINI Study Investigators , Ray , K K , Haq , I , Bilitou , A , Manu , M C , Burden , A , Aguiar , C , Arca , M , Connolly , D L , Eriksson , M , Ferrieres , J , Laufs , U , Mostaza , J M , Nanchen , D , Rietzschel , E , Strandberg , T , Toplak , H , Visseren , F L J & Catapano , A L 2023 , ' Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021 : the multinational observational SANTORINI study ' , Lancet regional health.Europe , vol. 29 , 100624 . https://doi.org/10.1016/j.lanepe.2023.100624Test; ORCID: /0000-0001-6299-925X/work/139113516; 20b9b921-60e8-4637-b3d6-61ed9b378a22; http://hdl.handle.net/10138/563421Test; 001001292500001

الإتاحة: http://hdl.handle.net/10138/563421Test

المؤلفون: Ray, Kausik K., Haq, Inaam, Bilitou, Aikaterini, Manu, Marius C., Burden, Annie, Aguiar, Carlos, Arca, Marcello, Connolly, Derek L., Eriksson, Mats, Ferrières, Jean, Laufs, Ulrich, Mostaza, Jose M., Nanchen, David, Rietzschel, Ernst, Strandberg, Timo, Toplak, Hermann, Visseren, Frank L.J., Catapano, Alberico L.

المصدر: The Lancet Regional Health - Europe ; volume 29, page 100624 ; ISSN 2666-7762

الإتاحة: https://doi.org/10.1016/j.lanepe.2023.100624Test
https://api.elsevier.com/content/article/PII:S2666776223000431?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2666776223000431?httpAccept=text/plainTest

المؤلفون: Ray, Kausik K, Aguiar, Carlos, Arca, Marcello, Connolly, Derek L, Eriksson, Mats, Ferrières, Jean, Laufs, Ulrich, Mostaza, Jose M, Nanchen, David, Bardet, Aurélie, Lamparter, Mathias, Chhabra, Richa, Soronen, Jarkko, Rietzschel, Ernst, Strandberg, Timo, Toplak, Hermann, Visseren, Frank L J, Catapano, Alberico L

المصدر: Eur J Prev Cardiol ; ISSN:2047-4881

مصطلحات موضوعية: Cardiovascular Risk, Dyslipidemia, Europe, Lipid, Real-World Clinical Trials

العلاقة: https://doi.org/10.1093/eurjpc/zwae199Test; https://pubmed.ncbi.nlm.nih.gov/38861400Test

الإتاحة: https://doi.org/10.1093/eurjpc/zwae199Test
https://pubmed.ncbi.nlm.nih.gov/38861400Test

المؤلفون: Delgado-Lista, Javier, Mostaza, Jose M., Arrobas-Velilla, Teresa, Blanco-Vaca, Francisco, Masana, Luis, Pedro-Botet, Juan, Perez-Martinez, Pablo, Civeira, Fernando, Cuende-Melero, Jose I., Gomez-Barrado, Jose J., Lahoz, Carlos, Pintó, Xavier, Suarez-Tembra, Manuel, Lopez-Miranda, Jose, Guijarro, Carlos

المصدر: Clínica e Investigación en Arteriosclerosis (English Edition) ; ISSN 2529-9123

مصطلحات موضوعية: General Earth and Planetary Sciences, General Engineering, General Environmental Science

الإتاحة: https://doi.org/10.1016/j.artere.2024.04.001Test
https://api.elsevier.com/content/article/PII:S2529912324000214?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2529912324000214?httpAccept=text/plainTest

المؤلفون: Ray, Kausik K., Haq, Inaam, Bilitou, Aikaterini, Aguiar, Carlos, Arca, Marcello, Connolly, Derek L., Eriksson, Mats, Ferrières, Jean, Hildebrandt, Per, Laufs, Ulrich, Mostaza, Jose M., Nanchen, David, Rietzschel, Ernst, Strandberg, Timo, Toplak, Hermann, Visseren, Frank L.J., Catapano, Alberico L.

المساهمون: HUS Internal Medicine and Rehabilitation, Timo Strandberg / Principal Investigator, Department of Medicine, Clinicum

مصطلحات موضوعية: Cardiovascular disease, High cardiovascular risk, LDL cholesterol, Lipid-lowering therapy, 3121 General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: KR has received lecture fees from Aegerion Pharmaceuticals, Kowa, Cipla, Algorithm, and Zuelling Pharma; grant support, paid to his institution, lecture fees, and advisory board fees from Amgen, Regeneron Pharmaceuticals/Sanofi, Daiichi Sankyo and Pfizer; lecture fees and fees for serving on steering committees for trials from AstraZeneca and Eli Lilly; fees for serving on steering committees for trials from Cerenis Therapeutics, the Medicines Company, and Esperion; advisory board fees from New Amsterdam Pharma, Akcea Therapeutics, Novartis, Silence Therapeutics, Bayer, and Daiichi Sankyo; lecture fees and advisory board fees from Takeda, Boehringer Ingelheim, and Dr. Reddy's Laboratories; consulting fees from Silence Therapeutics and Bayer; grant support and advisory board fees from Merck Sharp & Dohme; fees for serving on a clinical events adjudication committee from AbbVie; and fees for serving as principal investigator for a trial from Resverlogix. JF has received lecture fees from Amarin, Amgen, Lilly, Mylan, Sanofi and Servier. CA has received honoraria for consultancy and/or lectures fees from Abbott, Amgen, BIAL, Daiichi Sankyo, Merck Sharp & Dohme, Mylan, Servier and Tecnimede. DC has received fees for advisory boards, research and lectures from Amgen, Bayer, BMS, Boehringer Ingelheim, Daiichi Sankyo, Novartis, Pfizer and Sanofi. TS has received consulting fees and research and educational grants from Amgen, Novartis, Orion Pharma, Pfizer, Sankyo, Sanofi and Servier. HT has received lecture fees from Amgen, Daiichi Sankyo, Mylan, MSD, Novonordisk, Novartis, Pfizer and Sanofi, as well as research grants from Amgen, Daiichi Sankyo, Novartis, Novonordisk and Sanofi. MA has received research grant support and lecturing fees from Amgen, Amryt, IONIS/Akcea Therapeutics, Daiichi Sankyo, Novartis, Pfizer, Regeneron and Sanofi. ER has received unrestricted educational grants from Amgen, Merck Sharp & Dohme, AstraZeneca, Sanofi and Unilever, speakers' or consultancy fees from Daiichi Sankyo, Novonordisk, Boehringer Ingelheim, Amgen, Sanofi, Novartis and Teva; all paid directly to Ghent University. DN is or has been an investigator in clinical studies sponsored by Amgen, Pfizer, Daiichi Sankyo and Novartis; he has not received any personal fees for this work. JMM has received lecture and advisory board fees from Amgen, Daiichi Sankyo, Ferrer, Novartis, Pfizer and Sanofi. UL has received honoraria for lectures or consulting from Amgen, Daiichi Sankyo, Novartis and Sanofi. ME has received lecture and advisory board fees from Sanofi, and Amgen, advisory board fees from Akcea Therapeutics, and consulting fees from Novartis. IH and AB are employees of Daiichi Sankyo. FV and PH declare no conflicts of interest. This study is funded by Daiichi Sankyo Europe GmbH, Munich, Germany, who defined the study design, data collection and analysis. Six contract research organizations were contracted to conduct the study in 14 countries on behalf of Daiichi Sankyo Europe. Kausik Ray acknowledges support from the National Institute of Health Research Imperial Biomedical Research Centre. Alberico L. Catapano acknowledges support from the Italian Ministry of Health ? Ricerca Corrente ? IRCCS MultiMedica. The authors would like to thank Professor Robert Bryne, of Mater Private Hospital, Dublin, SANTORINI study coordinator for Ireland. The authors would also like to thank Carina Dinkel-Keuthage for support in statistical analysis set up and design of the study; Christine Bernhofer for study management; Stefan Courtney and Phil Jones of inScience Communications, Springer Healthcare Ltd, UK, for providing medical writing support, which was funded by Daiichi Sankyo Europe GmbH, Munich, Germany in accordance with Good Publication Practice (GPP3) guidelines (http://www.ismpp.org/gpp3Test). Kausik Ray acknowledges support from the National Institute of Health Research Imperial Biomedical Research Centre . Alberico L. Catapano acknowledges support from the Italian Ministry of Health – Ricerca Corrente – IRCCS MultiMedica.; Ray , K K , Haq , I , Bilitou , A , Aguiar , C , Arca , M , Connolly , D L , Eriksson , M , Ferrières , J , Hildebrandt , P , Laufs , U , Mostaza , J M , Nanchen , D , Rietzschel , E , Strandberg , T , Toplak , H , Visseren , F L J & Catapano , A L 2021 , ' Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study ' , Atherosclerosis Plus , vol. 43 , pp. 24-30 . https://doi.org/10.1016/j.athplu.2021.08.003Test; ORCID: /0000-0001-6299-925X/work/108865656; 85120624197; 4a3259c8-7629-481f-87d5-1044ce8ccecd; http://hdl.handle.net/10138/340669Test; 000787118200007

الإتاحة: http://hdl.handle.net/10138/340669Test

المؤلفون: Mostaza, José M., Suárez-Fernández, Carmen, Cosín-Sales, Juan, Gomez Huelgas, Ricardo, Brotons, Carlos, Araujo, Francisco Pestana, Borrayo, Gabriela, Ruiz, Emilio, Universitat Autònoma de Barcelona

مصطلحات موضوعية: Cardiovascular disease, Cardiovascular risk factors, Fixed-dose combination, Non-inferiority trial, Primary prevention, Polypill

وصف الملف: application/pdf

العلاقة: BMC Cardiovascular disorders; Vol. 22 (december 2022); https://ddd.uab.cat/record/281733Test; urn:10.1186/s12872-022-03013-w; urn:oai:ddd.uab.cat:281733; urn:pmcid:PMC9773517; urn:pmc-uid:9773517; urn:oai:pubmedcentral.nih.gov:9773517; urn:pmid:36550424

الإتاحة: https://ddd.uab.cat/record/281733Test

المؤلفون: Mostaza, José M, Suárez-Fernández, Carmen, Cosín-Sales, Juan, Gómez-Huelgas, Ricardo, Brotons, Carlos, Araujo, Francisco Pestana, Borrayo, Gabriela, Ruiz, Emilio, VULCANO investigators

مصطلحات موضوعية: Cardiovascular disease, Cardiovascular risk factors, Fixed-dose combination, Non-inferiority trial, Polypill, Primary prevention, Humans, Antihypertensive Agents, Cholesterol, LDL, Drug Combinations, Cardiovascular Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/10668/20264Test; PMC9773517; https://bmccardiovascdisord.biomedcentral.com/counter/pdf/10.1186/s12872-022-03013-wTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773517/pdfTest

الإتاحة: https://doi.org/10.1186/s12872-022-03013-wTest
http://hdl.handle.net/10668/20264Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773517/pdfTest

المؤلفون: Salinero-Fort, Miguel A., San Andrés-Rebollo, F. Javier, Cárdenas-Valladolid, Juan, Mostaza, José M., Lahoz, Carlos, Rodriguez-Artalejo, Fernando, Gómez-Campelo, Paloma, Vich-Pérez, Pilar, Jiménez-García, Rodrigo, López de Andrés, Ana, de Miguel-Yanes, José M.

المساهمون: Garikipati, Venkata Naga Srikanth, Instituto de Salud Carlos III, European Regional Development Fund, “A way of shaping Europe”

المصدر: PLOS ONE ; volume 17, issue 7, page e0271632 ; ISSN 1932-6203

الإتاحة: https://doi.org/10.1371/journal.pone.0271632Test

المؤلفون: Mostaza, Jose M., Salinero-Fort, Miguel A., Cardenas-Valladolid, Juan, Rodriguez-Artalejo, Fernando, Díaz-Almiron, Mariana, Vich-Pérez, Pilar, San Andres-Rebollo, F.Javier, Vicente, Ignacio, Lahoz, Carlos

المصدر: Atherosclerosis ; volume 341, page 13-19 ; ISSN 0021-9150

مصطلحات موضوعية: Cardiology and Cardiovascular Medicine

الإتاحة: https://doi.org/10.1016/j.atherosclerosis.2021.12.009Test
https://api.elsevier.com/content/article/PII:S0021915021015045?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0021915021015045?httpAccept=text/plainTest